Legal & General Group PLC Zentalis Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 4,940 shares of ZNTL stock, worth $14,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,940

Previous 4,940 -0.0%

Holding current value

$14,820

Previous $18,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.9 - $4.57 $153,517 - $241,922	-52,937 Reduced 91.46%	4,940 $18,000
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $4,392 - $17,323	1,074 Added 1.89%	57,877 $236,000
Q1 2024 May 14, 2024	BUY	$10.83 - $16.49 $13,277 - $20,216	1,226 Added 2.21%	56,803 $895,000
Q4 2023 Feb 15, 2024	SELL	$9.84 - $20.13 $1,830 - $3,744	-186 Reduced 0.33%	55,577 $841,000
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $16,764 - $24,159	854 Added 1.56%	55,763 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $272,257 - $469,921	15,638 Added 39.82%	54,909 $1.55 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $18,690 - $28,880	1,158 Added 3.04%	39,271 $675,000
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $7,101 - $10,060	393 Added 1.04%	38,113 $767,000
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $45,092 - $70,726	2,229 Added 6.28%	37,720 $817,000
Q2 2022 Aug 22, 2022	BUY	$17.91 - $52.25 $175,356 - $511,579	9,791 Added 38.1%	35,491 $998,000
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $650,727 - $1.27 Million	15,650 Added 155.72%	25,700 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $84,453 - $107,004	1,262 Added 14.36%	10,050 $845,000
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $198,652 - $311,787	4,242 Added 93.31%	8,788 $585,000
Q2 2021 Aug 12, 2021	BUY	$37.41 - $62.25 $13,280 - $22,098	355 Added 8.47%	4,546 $241,000
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $3,497 - $5,166	98 Added 2.39%	4,191 $182,000
Q4 2020 Feb 12, 2021	BUY	$31.71 - $57.97 $86,504 - $158,142	2,728 Added 199.85%	4,093 $212,000
Q3 2020 Nov 13, 2020	SELL	$27.03 - $47.97 $8,487 - $15,062	-314 Reduced 18.7%	1,365 $45,000
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $38,952 - $92,009	1,679 New	1,679 $81,000

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Zentalis Pharmaceuticals, Inc. Transaction History